Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 453-460

  Murata, Ken Ya ^a   Dalakas, Marines C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DERMATOMYOSITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFLAMMATION; MUSCLE BIOPSY; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032797798     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65141-3     Document Type: Article

References (25)

1. Emslie-Smith AM, Arahata K, Engel AG: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989, 20:224-231
2. Bender A, Ernst N, Iglesias A, Dornmair K, Wekerle H, Hohlfeld R: T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J Exp Med 1995, 181:1863-1868
3. Dalakas MC: Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 1998, 55:1509-1512
4. Reiser H, Stadecker MJ: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996, 335:1369-1377
5. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F: The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 1995, 54:175-187
6. Seko Y, Takahashi N. Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Suzuki S, Ishiwata S, Kawai S, Azuma M, Yagita H, Okumura K, Yazaki Y: Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 1998, 97:637-639
7. Behrens L, Kerschensteiner M, Misgeld T, Goebels N, Wekerle H, Hohlfeld R: Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998, 161:5943-5951
8. Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991, 325:1487-1498
9. Dalakas MC: Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995, 37(S1):S74-S86
10. Illa I, Dinsmore S, Dalakas WC: Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophiliamyalgia syndrome induced by L-tryptophan. Hum Pathol 1993, 24: 702-709
11. Dariavach P, Mattéi MG, Golstein P, Lefranc MP: Human Ig super-family CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988, 18:1901-1905
12. Lee KP, Taylor C, Petryniak B, Turka LA, June CH, Thompson CB: The genomic organization of the CD28 gene implications for the regulation of CD28 mRNA expression and heterogeneity. J Immunol 1990, 145:344-352
13. Ercolani L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988, 263:15335-15341
14. Schubert W, Zimmermann K, Cramer M, Starzinski-Powitz A: Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA 1989, 86:307-311
15. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM: Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993, 90:11059-11063
16. Freeman GJ, Cardoso AA, Boussiotis VA, Anumanthan A, Groves RW, Kupper TS, Clark EA, Nadler LM: The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J Immunol 1998, 161:2708-2715
17. Nickoloff BJ, Mitra RS, Lee K, Turka LA, Green J, Thompson C, Shimizu Y: Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol 1993, 142:1029-1040
18. Simon JC, Dietrich A, Mielke V, Wuttig C, Vanscheidt W, Linsley PS, Schöpf E, Sterry W: Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases. J Invest Dermatol 1994, 103:539-543
19. De Bleecker JL, Engel AG: Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994, 53:369-376
20. Bartoccioni E, Gallucci S, Scuderi F, Ricci E, Servidei S, Broccolini A, Tonali P: MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994, 95:166-172
21. Harding FA, Allison JP: CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993, 177:1791-1796
22. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology. 3rd Ed. Philadelphia, WB Saunders, 1997, pp 278-296
23. Lundberg I, Brengman JM, Engel AG: Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 1995, 63:9-16
24. Lane P: Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86. Ann NY Acad Sci 1997, 815:392-400
25. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258